1. Home
  2. LGND vs ORLA Comparison

LGND vs ORLA Comparison

Compare LGND & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • ORLA
  • Stock Information
  • Founded
  • LGND 1987
  • ORLA 2007
  • Country
  • LGND United States
  • ORLA Canada
  • Employees
  • LGND N/A
  • ORLA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • ORLA Precious Metals
  • Sector
  • LGND Health Care
  • ORLA Basic Materials
  • Exchange
  • LGND Nasdaq
  • ORLA Nasdaq
  • Market Cap
  • LGND 2.0B
  • ORLA 2.3B
  • IPO Year
  • LGND 1992
  • ORLA N/A
  • Fundamental
  • Price
  • LGND $114.07
  • ORLA $10.97
  • Analyst Decision
  • LGND Strong Buy
  • ORLA Hold
  • Analyst Count
  • LGND 8
  • ORLA 1
  • Target Price
  • LGND $144.71
  • ORLA $6.00
  • AVG Volume (30 Days)
  • LGND 116.0K
  • ORLA 1.3M
  • Earning Date
  • LGND 08-05-2025
  • ORLA 08-11-2025
  • Dividend Yield
  • LGND N/A
  • ORLA N/A
  • EPS Growth
  • LGND N/A
  • ORLA N/A
  • EPS
  • LGND N/A
  • ORLA 0.01
  • Revenue
  • LGND $181,488,000.00
  • ORLA $417,310,000.00
  • Revenue This Year
  • LGND $18.41
  • ORLA $158.56
  • Revenue Next Year
  • LGND $18.87
  • ORLA $13.13
  • P/E Ratio
  • LGND N/A
  • ORLA $2,154.92
  • Revenue Growth
  • LGND 53.40
  • ORLA 67.06
  • 52 Week Low
  • LGND $77.53
  • ORLA $3.24
  • 52 Week High
  • LGND $129.90
  • ORLA $12.43
  • Technical
  • Relative Strength Index (RSI)
  • LGND 62.44
  • ORLA 52.22
  • Support Level
  • LGND $111.88
  • ORLA $10.48
  • Resistance Level
  • LGND $116.16
  • ORLA $11.84
  • Average True Range (ATR)
  • LGND 3.58
  • ORLA 0.55
  • MACD
  • LGND 0.89
  • ORLA -0.02
  • Stochastic Oscillator
  • LGND 85.19
  • ORLA 25.13

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ORLA Orla Mining Ltd.

Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.

Share on Social Networks: